Biopharmaceutical Products Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Biopharmaceutical Products stocks.

Biopharmaceutical Products Stocks Recent News

Date Stock Title
May 24 BMY Terran Biosciences prepares for trials of schizophrenia drug
May 23 BMY Bristol Myers Squibb to Present Data at ASCO & EHA from More Than 130 Studies Across 25 Diseases Supporting Expansion into New Indications, Demonstrating Long-Term Survival, and Highlighting Novel Modalities and Research Platforms
May 23 BMY Bristol Myers Squibb: 5.5% Yielder Has Been Crushed In What Could Be A Generational Buying Opportunity
May 23 BMY Does Bristol-Myers Squibb (NYSE:BMY) Have A Healthy Balance Sheet?
May 23 TKNO Should You Believe in the Growth Prospects of Alpha Teknova (TKNO)?
May 23 BMY This Unpopular Dividend Stock Is a Buy
May 23 BMY Bristol Myers Squibb to Present Data at the 2024 American Society of Clinical Psychopharmacology Annual Meeting
May 22 RPRX Cytokinetics to get up to $575M in funding from Royalty Pharma
May 22 BMY Bristol-Myers Squibb snaps six days of losses, trades in the green
May 22 RPRX Royalty Pharma and Cytokinetics Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline
May 22 RPRX Cytokinetics and Royalty Pharma Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline
May 22 BMY Bristol-Myers, Sanofi liability in Hawaii Plavix litigation tops $900M
May 22 BMY Hawaii Court Rules Against Bristol Myers, Sanofi In Blood Clot Drug Case, Increases Liability To $916M
May 22 BMY Pfizer to Cut Costs in Multi-Year Effort
May 22 BMY Bristol Myers (BMY) Updates Action Date for Subcutaneous Opdivo
May 22 BMY Bristol Myers, Sanofi liability in Hawaii Plavix case grows to $916 million
May 22 BMY Bristol Myers Squibb Announces 10-Year Strategy to Reach More Patients in Low- and Middle-Income Countries
May 22 BMY Bristol-Myers Squibb Announces Strategies to Improve Access to Medicines
May 22 BMY NeoPhore closes oversubscribed Series B extension round with additional funding from Bristol Myers Squibb
May 22 BMY Hawaii court orders drug companies to pay $916 million in Plavix blood thinner lawsuit
Biopharmaceutical Products

Biopharmaceutical products are drugs or therapies that are produced using biotechnology. These products are created by manipulating living organisms or their components to make medicines that can be used to treat or prevent diseases. Examples of biopharmaceutical products include monoclonal antibodies, recombinant proteins, gene therapies, and vaccines.

Browse All Tags